Ian F. Smith - 13 Dec 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Signature: /s/ David Tyronne Howton as attorney-in-fact for Ian F. Smith
Issuer symbol: SLDB
Transactions as of: 13 Dec 2022
Transactions value $: $0
Form type: 4
Filing time: 15 Dec 2022, 17:15:58 UTC
Previous filing: 05 Dec 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SLDB	Common Stock						36.1K	13 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Director Stock Option (Right to Buy)	Award	$0	+9.65K		$0.00	9.65K	13 Dec 2022	Common Stock	9.65K	$6.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Amount reported has been adjusted to correct a mathematical error contained in the Form 4 filed by the Reporting Person on December 5, 2022.
F2	This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.